European Journal of Surgical Oncology
Volume 35, Issue 11 , Pages 1169-1173 , November 2009

Rigid sigmoidoscopy and MRI are not interchangeable in determining the position of rectal cancers

  • G. Baatrup

      Affiliations

    • Department of Surgery, Haukeland University Hospital, N5021 Bergen, Norway
    • Institute of Surgical Science, University of Bergen, N5021 Bergen, Norway
    • Corresponding Author InformationCorresponding author at: Department of Surgery, Haukeland University Hospital, N5021 Bergen, Norway. Tel.: +47 55972727; fax: +47 55972793.
    • ,
  • M. Bolstad

      Affiliations

    • Institute of Surgical Science, University of Bergen, N5021 Bergen, Norway
    • Department of Radiology, Haukeland University Hospital, N5021 Bergen, Norway
    • ,
  • J.H. Mortensen

      Affiliations

    • Department of Gynaecology, Haukeland University Hospital, N5021 Bergen, Norway

,Accepted 4 February 2009.

References 

  1. Swedish Rectal Cancer Trial . Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980–987
  2. Becker H, Liersch T. Upper rectal cancer 12–16cm above anocutaneous verge: TME or PME – followed by chemotherapy. Ann Oncol. 2008;19(Suppl. 1):23
  3. Kapitein E, Corrie AM, Marijnen MD, et al. Preoperative radiotherapy combined with total mesorectal excision for respectable rectal cancer. N Engl J Med. 2001;345:638–646
  4. Thumbe V, Iqbal M, Bhalerao S. Accuracy of digital rectal examination in the estimation of height of rectal lesions. Tech Coloproctol. 2007;11:111–113
  5. Gavioli M, Losi L, Lupi G, et al. Preoperative therapy for lower rectal cancer and modification in distance from anal sphincter. Int J Radiat Oncol Biol Phys. 2007;69:370–375
  6. Kim DW, Lim SB, Kim DY, et al. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3cm of the anal verge. Eur J Surg Oncol. 2006;32:162–167
  7. Ceelen W, Boterberg T, Pattyn P, et al. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer. Ann Surg Oncol. 2007;14:424–431
  8. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135–160
  9. Goligher JC. The operability of carcinoma of the rectum. BMJ. 1941;2:393–397
  10. Dukes CE. Cancer of the rectum on analysis of 1000 cases. J Pathol Bacteriol. 1940;46:527–539
  11. Bernardshaw SV, Øvrebø K, Eide GE, Skarstein A, Røkke O. Treatment of rectal cancer: reduction of local recurrence after the introduction of TME – experience from one university hospital. Dig Surg. 2006;23:51–59
  12. Eriksen MT, Wibe A, Haffner J, Wiig JN. Prognostic groups in 1676 patients with rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum. 2007;50:156–167
  13. Dulk M, Marijnen CA, Rutten HJT, et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the Dutch mesorectal excision trial. Ann Surg. 2007;246:83–90

PII: S0748-7983(09)00059-6

doi: 10.1016/j.ejso.2009.02.004

European Journal of Surgical Oncology
Volume 35, Issue 11 , Pages 1169-1173 , November 2009

Article Tools

* Image Usage & Resolution